WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark Bi-Cygni was filed as Word mark on 02/22/2022 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1680096 |
| Register number | UK00003376813 |
| Countries | 
|
| Base trademark |
No. UK00003376813,
May 10, 2019
|
| Application date | February 22, 2022 |
| Expiration date | February 22, 2032 |
Trademark owner
Mereside Alderley Park,
Alderley Edge
GB
Alderley Edge
GB
Trademark representatives
15 Clare Road
Halifax HX1 2HY
GB
goods and services
05
Antibodies; anti-cancer drugs; anticancer preparations;
anti-cancer preparations; anti-cancer preparations of
chemical origin; anti-cancer preparations of plant origin;
anti-infective antibiotics; anti-infective preparations;
anti-infectives; anti-inflammatories; antiparasitic
preparations; anti-viral agents; biological adjuvants for
medical purposes; biological preparations for medical
purposes; biological preparations for the treatment of
cancer; biological preparations for veterinary purposes;
biological reagents for medical use; biological reagents for
veterinary use; biological tissue cultures for medical
purposes; biopharmaceuticals for the treatment of cancer;
biotechnological preparations for medical use; blood
components; blood protein fractions; cardiovascular
pharmaceuticals; cardiovascular preparations; cells for
medical use; cellular function activating agents for medical
purposes; chemical adjuvants for medical purposes; chemical
preparations for medical purposes; chemical preparations for
pesticidal purposes; chemical preparations for
pharmaceutical purposes; chemical preparations for testing
blood for medical purposes; chemical reagents for medical
use; chemicals for pharmaceutical use; chemotherapeutics;
clinical diagnostic reagents; clinical medical reagents;
compounds for treating cancer; compounds for treating
correlated pulmonary syndromes; compounds for treating
respiratory diseases; cord blood; cord blood for medical
purposes; culture media for medical use; cultures for
medical use; cytostatic drugs for medical purposes;
cytostatics for medical purposes; cytostatics for
pharmaceutical purposes; diagnostic agents for medical use;
diagnostic agents for pharmaceutical use; diagnostic
biomarker reagents for medical purposes; diagnostic chemical
reagents for medical use; diagnostic preparations;
diagnostic preparations and materials; diagnostic
preparations for medical and veterinary use; diagnostic
preparations for medical or veterinary purposes; diagnostic
preparations for medical purposes; diagnostic reagents for
medical use; diagnostic reagents for medicinal use;
diagnostic substances for medical use; diagnostic testing
materials for medical use; drugs for medical purposes;
haemostatic preparations; homeopathic medicines; homeopathic
pharmaceuticals; immunomodulators; immunostimulants;
immunosuppressants for use following transplantation in the
case of graft rejection; immunotherapeutic agents for
bacterial infections; in vitro diagnostic preparations for
medical use; living cells for medical use; living cells for
veterinary use; medicine; medicines for human purposes;
medicines for intestinal disorders; medicines for the
treatment of gastrointestinal diseases; medicines for
treating intestinal disorders; pain relief preparations;
pharmaceutical compositions; pharmaceutical drugs;
pharmaceutical preparations; pharmaceutical preparations and
substances; pharmaceutical preparations and substances for
the prevention of cancer; pharmaceutical preparations and
substances for the treatment of cancer; pharmaceutical
preparations and substances for the treatment of
gastro-intestinal diseases; pharmaceutical preparations and
substances for use in gynecology; pharmaceutical
preparations and substances for use in oncology;
pharmaceutical preparations and substances for use in the
field of anesthesia; pharmaceutical preparations and
substances for use in urology; pharmaceutical preparations
and substances with anti-inflammatory properties;
pharmaceutical preparations and substances with antipyretic
properties; pharmaceutical preparations for activating
cellular function; pharmaceutical preparations for human
use; pharmaceutical preparations for inhalation for the
treatment of pulmonary hypertension; pharmaceutical
preparations for medical purposes; pharmaceutical
preparations for regulating the immune system;
pharmaceutical preparations for suppressing tumors;
pharmaceutical preparations for the prevention of allergies;
pharmaceutical preparations for the prevention of autoimmune
diseases; pharmaceutical preparations for the prevention of
autoimmune disorders; pharmaceutical preparations for the
prevention of diseases caused by bacteria; pharmaceutical
preparations for the prevention of diseases of the
cardio-vascular system; pharmaceutical preparations for the
prevention of diseases of the endocrine system;
pharmaceutical preparations for the prevention of diseases
of the genitourinary system; pharmaceutical preparations for
the prevention of diseases of the immune system;
pharmaceutical preparations for the prevention of diseases
of the metabolic system; pharmaceutical preparations for the
prevention of diseases of the musculo-skeletal system;
pharmaceutical preparations for the prevention of diseases
of the nervous system; pharmaceutical preparations for the
prevention of diseases of the respiratory system;
pharmaceutical preparations for the prevention of disorders
caused by bacteria; pharmaceutical preparations for the
prevention of disorders of the cardio-vascular system;
pharmaceutical preparations for the prevention of disorders
of the endocrine system; pharmaceutical preparations for the
prevention of disorders of the genitourinary system;
pharmaceutical preparations for the prevention of disorders
of the immune system; pharmaceutical preparations for the
prevention of disorders of the metabolic system;
pharmaceutical preparations for the prevention of disorders
of the musculo-skeletal system; pharmaceutical preparations
for the prevention of disorders of the nervous system;
pharmaceutical preparations for the prevention of disorders
of the respiratory system; pharmaceutical preparations for
the prevention of inflammatory diseases; pharmaceutical
preparations for the prevention of inflammatory disorders;
pharmaceutical preparations for the prevention of ocular
diseases; pharmaceutical preparations for the prevention of
ocular disorders; pharmaceutical preparations for the
prevention of osteoporosis; pharmaceutical preparations for
the prevention of tumours; pharmaceutical preparations for
the treatment of autoimmune diseases; pharmaceutical
preparations for the treatment of autoimmune disorders;
pharmaceutical preparations for the treatment of bone
diseases; pharmaceutical preparations for the treatment of
cancer; pharmaceutical preparations for the treatment of
cardiovascular disease; pharmaceutical preparations for the
treatment of central nervous system [cns] diseases;
pharmaceutical preparations for the treatment of digestive
diseases; pharmaceutical preparations for the treatment of
diseases caused by bacteria; pharmaceutical preparations for
the treatment of diseases of the endocrine system;
pharmaceutical preparations for the treatment of diseases of
the genitourinary system; pharmaceutical preparations for
the treatment of diseases of the metabolic system;
pharmaceutical preparations for the treatment of diseases of
the musculo-skeletal system; pharmaceutical preparations for
the treatment of disorders caused by bacteria;
pharmaceutical preparations for the treatment of disorders
of the endocrine system; pharmaceutical preparations for the
treatment of disorders of the genitourinary system;
pharmaceutical preparations for the treatment of disorders
of the metabolic system; pharmaceutical preparations for the
treatment of epilepsy; pharmaceutical preparations for the
treatment of esophagitis; pharmaceutical preparations for
the treatment of eye diseases and conditions; pharmaceutical
preparations for the treatment of gout; pharmaceutical
preparations for the treatment of heart rhythm disorders;
pharmaceutical preparations for the treatment of hormonal
disorders; pharmaceutical preparations for the treatment of
hypercholesteremia; pharmaceutical preparations for the
treatment of hyperlipidemia; pharmaceutical preparations for
the treatment of immune system related diseases and
disorders; pharmaceutical preparations for the treatment of
infectious diseases; pharmaceutical preparations for the
treatment of inflammatory diseases; pharmaceutical
preparations for the treatment of inflammatory disorders;
pharmaceutical preparations for the treatment of kidney
diseases; pharmaceutical preparations for the treatment of
kidney disorders; pharmaceutical preparations for the
treatment of multiple sclerosis; pharmaceutical preparations
for the treatment of musculo-skeletal disorders;
pharmaceutical preparations for the treatment of
musculo-skeletal disorders; pharmaceutical preparations for
the treatment of osteoporosis; pharmaceutical preparations
for the treatment of parkinson's disease; pharmaceutical
preparations for the treatment of tumours; pharmaceutical
preparations for the treatment of viral diseases;
pharmaceutical preparations for treating allergic rhinitis;
pharmaceutical preparations for treating allergies;
pharmaceutical preparations for treating arthritis;
pharmaceutical preparations for treating asthma;
pharmaceutical preparations for treating chemical
imbalances; pharmaceutical preparations for treating
diabetes; pharmaceutical preparations for treating digestive
system disorders; pharmaceutical preparations for treating
epidermal problems; pharmaceutical preparations for treating
gastrointestinal disorders; pharmaceutical preparations for
treating hypertension; pharmaceutical preparations for
treating hypoglycemia; pharmaceutical preparations for
treating malignant tumors; pharmaceutical preparations for
treating metabolic disorders; pharmaceutical preparations
for treating peripheral nervous system disorders;
pharmaceutical preparations for treating respiratory
diseases; pharmaceutical preparations for treating
rheumatological diseases; pharmaceutical preparations for
treating sensory organ disorders; pharmaceutical
preparations for treating skeletal diseases; pharmaceutical
preparations for treating skin disorders; pharmaceutical
preparations for treating the symptoms of radiation
sickness; pharmaceutical preparations for use in
chemotherapy; pharmaceutical preparations for use in
dermatology; pharmaceutical preparations for use in
hematology; pharmaceutical preparations for use in oncology;
pharmaceutical preparations for use in ophthalmology;
pharmaceutical preparations for use in organ
transplantation; pharmaceutical preparations for use in
tissue transplantation; pharmaceutical preparations for use
in urology; pharmaceutical preparations for veterinary use;
pharmaceutical products for the treatment of bone diseases;
pharmaceutical products for the treatment of cancer;
pharmaceutical products for the treatment of infectious
diseases; pharmaceutical products for the treatment of viral
diseases; pharmaceutical products for treating respiratory
diseases; pharmaceuticals; pharmaceuticals and natural
remedies; pharmacological preparations for skin care;
preparations for the treatment of asthma; radioactive
substances for medical purposes; radio-isotope markers for
therapeutic or diagnostic use; radiological contrast
substances for medical purposes; radiopharmaceutical
products; reagents for analytical purposes [for medical
purposes]; reagents for analytical purposes [for veterinary
purposes]; reagents for in-vitro laboratory use [for medical
purposes]; reagents for in-vitro laboratory use [for
veterinary purposes]; reagents for medical use; reagents for
use in diagnostic tests [for medical purposes]; reagents for
use in diagnostic tests [for veterinary purposes];
reconstituted cells for clinical treatments for skin care;
reconstituted cells for medical treatments for skin care;
tissue-regenerative pharmaceutical preparations; tissues for
medical use
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| June 22, 2023 | 2023/25 Gaz | JP | Rejection |
| April 14, 2023 | 2023/18 Gaz | RAW: Limitation | |
| March 15, 2023 | 2023/11 Gaz | CN | Rejection |
| February 28, 2023 | 2023/9 Gaz | NZ | Rejection |
| February 8, 2023 | 2023/6 Gaz | US | Rejection |
| January 19, 2023 | 2023/3 Gaz | EM | Rejection |
| January 18, 2023 | 2023/3 Gaz | AU | Rejection |
| February 22, 2022 | 2022/33 Gaz | GB | Registration |
ID: 141680096